Lacosamida Pentafarma

Lacosamide, the active ingredient in Lacosamida Pentafarma, is a sodium channel blocker presented as a tablet for oral use. It is used as adjunctive therapy for partial‑onset seizures in patients with epilepsy.

GNH USA supplies Lacosamida Pentafarma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an antiepileptic drug indicated for seizure disorders.

Partial‑onset seizures: reduces seizure frequency when added to existing antiepileptic regimens. Focal epilepsy: improves overall seizure control as adjunctive therapy. Adjunctive therapy in epilepsy: used together with other agents to achieve better seizure management.

Lacosamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Fatigue - Somnolence - Diplopia

Serious or Rare Side Effects: - Cardiac arrhythmias (e.g., PR‑interval prolongation) - Suicidal thoughts or behavior - Severe skin reactions such as Stevens‑Johnson syndrome - Hypersensitivity reactions including anaphylaxis - Rhabdomyolysis

When prescribing Lacosamide, clinicians should consider several safety aspects. - Renal impairment: evaluate dose adjustments and monitor renal function. - Hepatic impairment: use caution and monitor liver enzymes. - Cardiac conduction abnormalities: obtain baseline ECG and monitor for PR‑interval changes. - Pregnancy: risk category unknown; discuss potential benefits and risks with the patient. - Concomitant CNS depressants: monitor for enhanced sedation or respiratory depression. - Store at room temperature: keep in the original container, protect from moisture and light.

Lacosamide can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, lowering lacosamide plasma levels. - Phenytoin: reduces lacosamide concentrations through enzyme induction. - Rifampin: markedly decreases lacosamide exposure.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, alcohol): may increase sedation. - Other antiepileptics (e.g., valproate): monitor seizure control and side‑effects. - Serotonergic agents (e.g., SSRIs, tramadol): risk of serotonin syndrome, observe for symptoms.